New Report on Pharma Product Launches by FirstWord
06 Jan 2012 • by Natalie Aster
A tighter economic climate, shifting dynamics from prescribers to payers and increased generic competition have all meant that not only are there fewer pipeline drugs, there are fewer successful product launches. And those that do launch are not sufficient to contribute to market growth or even replace revenue from off-patent drugs.
The new study “Pharma Product Launches: Strategies for Success” by FirstWord looks at how successful launch strategies can place pharmaceutical companies in a strong position, despite the weak market. The report, based on expert interviews and case studies, explains how and when to initiate launch planning and stakeholder engagement, the importance of creating pre-launch awareness and the importance of product differentiation. In careful detail, the report outlines the key elements of launch programs and highlights the opportunities and challenges that the industry faces in launching a new drug in primary care and specialty markets.
Pharma Product Launches: Strategies for Success
Published: Oct, 2011
Price: US$ 595,00
- Overview of the changing pharmaceutical landscape and how challenges will affect future product launches
- Breakdown on initiating launch planning and successfully implementing launch strategies
- Discussion of the importance product differentiation
- Case studies detailing product launches for both primary care and specialist markets
More information can be found in the report “Pharma Product Launches: Strategies for Success” by FirstWord.
To order the report or ask for sample pages contact [email protected]